1 Min Read
March 2 (Reuters) - Edge Therapeutics Inc
* Edge Therapeutics reports fourth quarter and full year 2016 financial results
* Qtrly loss per share $0.33 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.